Menu

Image of the Day: An Eyeful

The physiological changes that can occur in the retinas of patients with cerebral malaria may provide a useful approach to diagnosis.

Apr 30, 2018
The Scientist Staff, The Scientist Staff

Severe Plasmodium falciparum malaria infections can often be diagnosed by examining a patient’s retina because the disease can cause changes in the blood vessels and the retina’s color. The prognostic significance of this outcome was not clear until recently, however. Researchers reported last month (March 26) in eLife that certain changes in the retina’s fovea—namely, foveal whitening and orange, defective blood vessels—are strongly associated with death in patients with cerebral malaria. The findings may provide a useful marker for diagnosing severe infections, the researchers write.

V. Berrera et al., “Neurovascular sequestration in paediatric P. falciparum malaria is visible clinically in the retina,” eLife, doi:10.7554/eLife.32208, 2018.

July/August 2019

On Target

Researchers strive to make individualized medicine a reality

Marketplace

Sponsored Product Updates

DNASTAR® announced the release of Lasergene 16 Software
DNASTAR® announced the release of Lasergene 16 Software
DNASTAR® announced the release of Lasergene 16 today, which includes a broad range of improvements in for analysis of DNA, RNA and protein sequence data, as well as new advancements for predicting and analyzing protein structures. 
Arbor Biosciences Partners with Curio Genomics for Analysis of IWGSC Wheat Exome
Arbor Biosciences Partners with Curio Genomics for Analysis of IWGSC Wheat Exome
Arbor Biosciences, a division of Chiral Technologies, Inc and worldwide leader in next generation sequencing (NGS) target enrichment, announces a partnership with Curio Genomics for bioinformatics analysis of the wheat genome.
IDT and Washington University join forces to increase access to the latest NGS technologies
IDT and Washington University join forces to increase access to the latest NGS technologies
As part of its commitment to advocate for the genomics age, Integrated DNA Technologies (IDT) aims to lower the barriers to access the latest NGS technologies.
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) July 15, 2019 announced the launch of its Bio-Plex Pro Human Immunotherapy Panel 20-plex, a multiplex immunoassay that offers a targeted approach for Immunotherapy Research.